The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry

NCT ID: NCT05811780

Last Updated: 2023-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-04-29

Study Completion Date

2035-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Condition Requiring Extracorporeal Organ Support

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Treatment with any kind of extracorporeal organ support

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Freiburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PD Dr. Alexander Supady

Co-Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tobias Wengenmayer, Prof. Dr.

Role: STUDY_DIRECTOR

University of Freiburg

Dawid L Staudacher, PD Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Freiburg

Paul M Biever, Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Freiburg

Jonathan Rilinger, PD Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Freiburg

Alexander Supady, PD Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Freiburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Freiburg Medical Center

Freiburg im Breisgau, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tobias Wengenmayer, Prof. Dr.

Role: CONTACT

+49761270 ext. 35910

Alexander Supady, PD Dr.

Role: CONTACT

+49761270 ext. 73790

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tobias Wengenmayer, Prof. Dr.

Role: primary

+49761270 ext. 35910

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

151/14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.